For current publications please use the following link to search the PubMed web site for recent articles published by the Division of Immunology faculty.

www.ncbi.nlm.nih.gov/Pubmed
*Note: this will open a new window. Simply close the window to return here.

SELECTED PUBLICATIONS

Urban JF Jr, Norben-Trauth N, Donaldson DD, Madden KB, Morris SC, Collins M, Finkelman FD. IL-13, IL-4R, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity. 1998; 8:255-64.

Morris SC, Coffman RL, Finkelman FD. In vivo IL-4 responses to anti-IgD antibody are MHC Class II-dependent,  2 -microglobulin-independent, and Stat6-independent. J Immunol. 1998; 160:3299-304.

Sheikh JS, Retzinger GS, Hess EV. Association of Osteonecrosis (ON) in Systemic Lupus Erythematosus (SLE) with Abnormalities of Fibrinolysis.  Lupus. 1998; 7:42-48.

Morris SC, Moroldo M, Giannini EH, Orekhova T, Finkelman FD. In vivo survival of autoreactive B cells: Characterization of long-lived B cells. J. Immunol. 2000; 164:3035-3046.

Farhey Y, Luggen M.  Seropositive, symmetric polyarthritis in a patient with poorly differentiated lung carcinoma:  carcinomatous polyarthritis, hypertrophic osteoarthropathy, or rheumatoid arthritis?  Arthritis Care Res. 1998; 11(2):146-149.

Finkelman FD, Morris SC, Orekhova T, Mori M, Donaldson D, Reiner SL, Reilly NL, Schopf L, Urban JF Jr.  Stat 6 regulation of in vivo IL-4 responses.  J Immunol. 2000; 164:2303-2310.

Bernstein IL, Bernstein JA, Miller M, Tierzieva S, Bernstein DI, Lummus Z, Selgrade MK, Doerfler DL, Seligy VL. Immune responses in farm animals after exposure to Bacillus thuringiensis pesticides.  Environ Health Perspect. 1999; 107(7):575-582.

Bernstein JA, Bernstein DI, Stauder T, Lummus Z, Bernstein IL. A cross-sectional survey of sensitization to Aspergillus oryzae - derived lactase in pharmaceutical workers.  J Allergy Clin Immunol. 1999; 103(6):1153-57.

Mongey AB, Sim E, Risch A, Hess E. Acetylation status is associated with serological changes but not clinically significant disease in patients receiving procainamide.  J Rheumatol. 1999; 26(8):1721-26.